Contrast Enhanced Digital Mammography (CEDM) Market Trends - Brief Analysis by Top Key Players

AI-powered Image Processing Forms Gold Standard for Breast Cancer Diagnosis

The contrast enhanced digital mammography (CEDM) market is witnessing change with the introduction of software in mammography equipment. Advancements in mammography software are anticipated to create incremental opportunities for healthcare companies. Mammography software is boosting clinical confidence and bolstering the efficiency of mammography systems. Companies in the contrast enhanced digital mammography (CEDM) market are increasing R&D to development equipment that automatically detect breast density with the help of AI-powered image processing and computer-aided detection.

Companies in the contrast enhanced digital mammography (CEDM) market are taking keen interest in applications that offer shorter time for diagnosis. Specificity and sensitivity are setting benchmark for gold standard diagnosis for breast cancer. Since examinations are being performed in a matter of few minutes, growing awareness about breast cancer has encouraged women to undergo screening for early diagnosis of the condition. Hence, companies in the market for contrast enhanced digital mammography (CEDM) are advancing to make improvements in image acquisition processes in order to virtually prevent the issue of artifacts caused due to patient motion.

To know the scope of our report Get a Sample on Contrast Enhanced Digital Mammography (CEDM) Market      

Cost and Time Efficiency of Mammography-guided Biopsy Techniques Gain Increased Popularity

Interventional and biopsy procedures play a crucial role in the diagnosis of breast cancer. Hence, companies are increasing efforts in mammography-guided biopsy techniques. For instance, in November 2019, the U.S. provider of diagnostic imaging agents, GE Healthcare, announced the launch of first-of-its-kind contrast-enhanced mammography solution Serena Bright™ for biopsy. 

Mammography-guided biopsy techniques are pervasively replacing conventional mammography and ultrasound in the contrast enhanced digital mammography (CEDM) market. Since breast MR is more time consuming, costly, and uncomfortable for patients, contrast-enhanced mammography solutions are gaining popularity in the market for contrast enhanced digital mammography.

Get a glimpse of the in-depth analysis through our Report Brochure

Contrast-enhanced mammography solutions are anticipated to become mainstream in the market for contrast enhanced digital mammography to diagnose lesions. This is justified since in 2018, diagnostics held a leading share of the contrast enhanced digital mammography (CEDM) market. Mammography-guided biopsy techniques are being highly publicized for their cost and time efficiency. Such novel techniques are anticipated to improve patient experience and outcomes. Thus, the mammography-guided biopsy technique is a potential alternative solution to traditional MR-guided breast biopsy.

Breast CT versus Digital Mammography: Which is better?

Innovations in breast imaging are emerging in the market for contrast enhanced digital mammography (CEDM) for diagnostic evaluation of symptomatic cancer patients. On the other hand, contrast-enhanced mammography solutions are creating a significant impact on breast imaging capabilities. This is evident since the contrast enhanced digital mammography (CEDM) market is anticipated to grow at a striking CAGR of ~11% during the forecast period. However, healthcare companies in the market landscape are facing tough competition due to the advancement in technology used in dedicated cone beam breast computed tomography (CBBCT).

CBBCT is found to eliminate painful compression and manipulation of the breast. This phenomena is common in digital mammography. Hence, companies in the contrast enhanced digital mammography (CEDM) market are focusing on technical improvements in mammography equipment. They are harnessing the advantages of AI to improve the image acquisition process. Market players are increasing are experimenting with advanced reconstruction algorithms in order to enhance micro-calcifications.

Innovations in breast imaging are emerging in the market for contrast enhanced digital mammography (CEDM) for diagnostic evaluation of symptomatic cancer patients. On the other hand, contrast-enhanced mammography solutions are creating a significant impact on breast imaging capabilities. This is evident since the contrast enhanced digital mammography (CEDM) market is anticipated to grow at a striking CAGR of ~11% during the forecast period. However, healthcare companies in the market landscape are facing tough competition due to the advancement in technology used in dedicated cone beam breast computed tomography (CBBCT).

Expanding operations in future? To get the perfect launch ask for a custom report